On 9 October at 12:05 pm, Managing Director David Blackburn will speak during Pharma Law USA at the Westin Copley Place in Boston, Massachusetts, hosted by Informa. Dr. Blackburn will participate in the “Focus on Biologics & Biosimilars: Antitrust, IP & Other Issues” panel. The panel will review IP issues and recent antitrust case law while addressing the practical implications for products entering the market and whether there is a need for regulatory changes. Pharma Law USA examines the latest developments affecting pharma including antitrust, IP, fraud, and compliance and regulation.
On 9 October at 12:05 pm, Managing Director David Blackburn will speak during Pharma Law USA at the Westin Copley Place in Boston, Massachusetts, hosted by Informa. Dr. Blackburn will participate in the “Focus on Biologics & Biosimilars: Antitrust, IP & Other Issues” panel. The panel will review IP issues and recent antitrust case law while addressing the practical implications for products entering the market and whether there is a need for regulatory changes. Pharma Law USA examines the latest developments affecting pharma including antitrust, IP, fraud, and compliance and regulation.
